Compare SOPH & HIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SOPH | HIX |
|---|---|---|
| Founded | 2011 | 1998 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 374.1M | 376.5M |
| IPO Year | 2021 | 1998 |
| Metric | SOPH | HIX |
|---|---|---|
| Price | $5.75 | $3.92 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $7.50 | N/A |
| AVG Volume (30 Days) | 236.0K | ★ 309.4K |
| Earning Date | 05-05-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 13.14% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $23.09 | N/A |
| Revenue Next Year | $19.57 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.83 | $3.75 |
| 52 Week High | $5.71 | $4.39 |
| Indicator | SOPH | HIX |
|---|---|---|
| Relative Strength Index (RSI) | 66.47 | 42.78 |
| Support Level | $4.59 | $3.89 |
| Resistance Level | N/A | $4.04 |
| Average True Range (ATR) | 0.36 | 0.04 |
| MACD | 0.07 | -0.00 |
| Stochastic Oscillator | 87.17 | 16.67 |
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
Western Asset High Income Fund II Inc is a diversified closed-end management investment company. Its investment objective is to maximize current income by investing at least 80% of its net assets and borrowings for investment purposes in high-yield debt securities.